Sites Overwhelmed by Cost and Trial Complexity, Need Sponsor Help to Bear the Burden – CenterWatch Weekly Article by WCG

by Melissa Patania-McNamara | Sep 15, 2020 | Industry, News, Research, Uncategorized

Article by Leslie Ramsey at WCG. Source here. Article is in reference to webinar “How Sanofi’s SMILE Program Drove the Changes We Need Now” from September 9th 2020. Webinar information can be found here. ________ Dwindling clinical trial financial resources caused by...

WCG WEBINAR: How Sanofi’s SMILE Program Drove the Changes We Need Now – September 9th 2020 @2pm ET

by Melissa Patania-McNamara | Sep 3, 2020 | Uncategorized

Date / Time: Wednesday, September 9th at 2:00pm ET (1 Hour Webinar) Now, more than ever, the partnership between sites and sponsors is essential, as we all navigate the changing site environment and workflows necessitated by COVID-19. With their acclaimed “SMILE”...

PUBLISHED: LMC Manna Physicians publish paper on the burden of NAFLD in Canada

by Melissa Patania-McNamara | Jul 13, 2020 | Industry, Research, Uncategorized

Research physicians at LMC Manna Research have joined forces with noted healthcare professionals to focus on the prevention of NAFLD & NASH, and their increasing burden on Canadians. We would like to applaud our very own Dr. Harpreet S. Bajaj MD & Dr Paul...

RESEARCH SPOTLIGHT: Insulin glargine/lixisenatide fixed-ratio combination improves glycaemic variability and control without increasing hypoglycaemia

by LMC Manna Research | Feb 27, 2019 | Uncategorized

LMC Manna Research’s Chief Medical officer Dr. Ronnie Aronson shares our latest publication showcasing our collaborative work with the medications lixisenatide and LixiLan (lixisenatide & lantus combination) over the past decade. This publication is a...

RESEARCH SPOTLIGHT: Reproducibility in the cardiometabolic responses to high-intensity interval exercise in adults with type 1 diabetes

by LMC Manna Research | Feb 1, 2019 | Uncategorized

With one month of 2019 already completed, we are excited to share a 2nd FIT published paper from LMC Manna Research’s very own Scientist Team led by Chief Medical Officer Dr. Ronnie Aronson and Senior Scientist Michael Riddell. This 2nd paper highlights that High...

Manuscript Accepted: SGLT2 inhibitors and incretin agents: associations with alanine aminotransferase activity in type 2 diabetes

by LMC Manna Research | Sep 25, 2018 | Uncategorized

LMC Healthcare & LMC Manna Researches own Drs. Ronnie Aronson, Harpreet Bajaj, and Ruth Brown’s manuscript titled “SGLT2 inhibitors and incretin agents: associations with alanine aminotransferase activity in type 2 diabetes” has been accepted to...